4d Molecular Therapeutics In shares owned by UBS Group
Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in 4d Molecular Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including 4d Molecular Therapeutics In held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in 4d Molecular Therapeutics In by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $825k | 95k | 8.69 |
| 2025-06-30 | $358k | 97k | 3.71 |
| 2025-03-31 | $764k | 236k | 3.23 |
| 2024-12-31 | $543k | 98k | 5.57 |
| 2024-09-30 | $868k | 80k | 10.81 |
| 2024-06-30 | $1.4M | 67k | 21.00 |
| 2024-03-31 | $12M | 374k | 31.86 |
| 2023-12-31 | $1.7M | 86k | 20.26 |
| 2023-09-30 | $572k | 45k | 12.73 |
| 2023-06-30 | $973k | 54k | 18.07 |
| 2023-03-31 | $901k | 52k | 17.19 |
| 2022-12-31 | $904k | 41k | 22.21 |
| 2022-06-30 | $0 | 35 | 0.00 |
| 2022-03-31 | $2.0M | 70k | 28.57 |
| 2021-12-31 | $2.0M | 69k | 28.57 |
| 2021-09-30 | $34k | 1.3k | 27.07 |
| 2021-03-31 | $893k | 21k | 43.37 |